| Members |
targetComponentId |
| Disease of endocrine gland |
Disorder of endocrine gonad |
| Disease of supporting structures of teeth |
Periodontal disease |
| Disease of teeth |
Tooth disorder |
| Disease of thymus gland, NEC |
Disorder of thymus gland |
| hämningslöshet orsakad av intagbar alkohol |
Disinhibition caused by ethanol |
| dinatriumedetatallergi |
Allergy to edetate (finding) |
| biverkning av dinatriumetidronat |
Adverse reaction to etidronic acid |
| dinatriumetidronatallergi |
Allergy to etidronic acid (finding) |
| allergi mot dinatriumetidronat och kalciumkarbonat |
Allergy to etidronic acid (finding) |
| biverkning av dinatriumpamidronat |
Adverse reaction to pamidronic acid (disorder) |
| dinatriumpamidronatallergi |
Allergy to pamidronic acid (finding) |
| Disodium tiludronate |
Product containing tiludronic acid (medicinal product) |
| Disopyramide phosphate 100mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
| disopyramidfosfat 100 mg, kapsel med modifierad frisättning |
Disopyramide only product in oral dose form |
| disopyramidfosfat 100 mg, tablett med modifierad frisättning |
Disopyramide only product in oral dose form |
| disopyramidfosfat 100 mg, depåkapsel |
Disopyramide only product in oral dose form |
| disopyramidfosfat 100 mg, depåtablett |
Disopyramide only product in oral dose form |
| Disopyramide phosphate 150mg |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
| Disopyramide phosphate 150mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
| disopyramidfosfat 150 mg, kapsel med modifierad frisättning |
Disopyramide only product in oral dose form |
| disopyramidfosfat 150 mg, depåkapsel |
Disopyramide only product in oral dose form |
| sjukdom efter anatomisk lokalisation |
Disease |
| Disorder involving the integument of fetus or newborn, NEC |
Disorder involving the integument of fetus OR newborn |
| Disorder of amino acid transport |
Amino acid transport disorder |
| sjukdom i autonoma nervsystemet orsakad av substans |
Disorder of autonomic nervous system |
| Disorder of balance |
Impairment of balance (finding) |
| tyfoid hjärtsjukdom |
Infection of heart caused by Salmonella enterica subspecies enterica serovar Typhi (disorder) |
| Disorder of hemostasis |
Blood coagulation disorder |
| Disorder of iris AND/OR ciliary body |
Disorder of uveal tract |
| Disorder of pregnancy |
Disorder of pregnancy |
| Disorder of skeletal muscle |
Disorder of skeletal muscle |
| Disorder of transport, NEC |
Metabolic disorder of transport |
| sjukdom primärt manifesterad som korea |
Chorea |
| Dispensing of unlisted low vision aid |
Fitting and dispensing of spectacles |
| Displaced tooth |
Displaced tooth |
| Displacement - action |
Action |
| förskjutning av bröstimplantat |
Displacement of prosthetic breast implant (disorder) |
| dislokation, grad 1 |
Displacement |
| dislokation, grad 2 |
Displacement |
| dislokation, grad 3 |
Displacement |
| Disproportion of other origin, NEC |
Disproportion between fetus and pelvis (disorder) |
| upprivet episiotomisår |
Disruption of episiotomy wound in the puerperium (disorder) |
| upprivet lacerationssårställe |
Disrupted wound |
| dissekerande aneurysm i koronarartär |
Dissection of coronary artery (disorder) |
| Disseminated chorioretinitis and retinochoroiditis NOS |
Disseminated chorioretinitis |
| Disseminated paracoccidioidomycosis |
Disseminated paracoccidioidomycosis (disorder) |
| Dist fasciocutaneous flap NOS |
Distant fasciocutaneous flap |
| distal interfalangealled i stortå, struktur |
Interphalangeal joint structure of great toe |
| distal monosomi 20q |
20q13.33 microdeletion syndrome (disorder) |
| distal myopati med tidigt engagemang av andningsmuskler |
Hereditary myopathy with early respiratory failure |
| Distant cutaneous pedicle skin flap NOS |
Reconstruction using distant pedicle skin flap |
| Distant fasciocutaneous flap to head or neck NEC |
Distant fasciocutaneous flap |
| Distant free flap reconstruction - action |
Distant flap reconstruction - action (qualifier value) |
| Distant myocutaneous flap NOS |
Distant myocutaneous flap |
| Distant myocutaneous flap to head or neck NEC |
Distant myocutaneous flap |
| Distant pedicle flap reconstruction - action |
Distant flap reconstruction - action (qualifier value) |
| Distant skin flap to head or neck NEC |
Reconstruction with distant flap |
| Distant subcutaneous pedicle flap, axial pattern NEC |
Reconstruction using distant subcutaneous pedicle axial pattern flap (procedure) |
| Distant subcutaneous pedicle flap, fasciocutaneous NEC |
Distant fasciocutaneous flap |
| Distant subcutaneous pedicle flap, myocutaneous NEC |
Distant myocutaneous flap |
| Distant subcutaneous pedicle flap, random pattern NEC |
Reconstruction using distant subcutaneous pedicle random pattern flap (procedure) |
| Disto-occlusion |
Disto-occlusion of teeth |
| Disturbance in form of thinking |
Disorder of form of thought |
| ditranolkrämallergi |
Allergy to dithranol (finding) |
| ditranolsalvaallergi |
Allergy to dithranol (finding) |
| ditranolpastaallergi |
Allergy to dithranol (finding) |
| divalproexnatrium 125 mg, tablett med fördröjd frisättning |
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| divalproexnatrium 250 mg, tablett med fördröjd frisättning |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| divalproexnatrium 500 mg, tablett med modifierad frisättning |
Valproic acid only product in oral dose form |
| divalproexnatrium 500 mg, depåtablett |
Valproic acid only product in oral dose form |
| Diversional therapy |
Diversional therapy |
| divisionen Tenericutes |
Phylum Tenericutes (organism) |
| delning av palmaraponeuros vid kirurgisk behandling av Dupuytrens kontraktur |
Division of palmar aponeurosis for correction of Dupuytren contracture (procedure) |
| dobutamin 12,5 mg/ml, infusionskoncentrat, flaska 20 ml |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| dobutamin 50 mg/ml, infusionskoncentrat, ampull 5 ml |
Dobutamine (as dobutamine hydrochloride) 50 mg/mL solution for injection |
| Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| gör inte |
Does not |
| vaccin mot hundallergi |
Dog allergy vaccine (product) |
| Doll's eye sign |
Doll's head reflex |
| Dolphin distemper virus |
Cetacean morbillivirus (organism) |
| Domain Archaea |
Domain Archaea |
| Domestic animal species, non-primate |
Class Mammalia (organism) |
| Domestic animals |
Class Mammalia (organism) |
| patientens partner i hemmet |
Domestic partner (person) |
| donepezil 10 mg, munsönderfallande tablett |
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| donepezil 1mg/ml, oral lösning |
Donepezil hydrochloride 1 mg/mL oral solution |
| donepezil 5 mg, munsönderfallande tablett |
Donepezil hydrochloride 5 mg orodispersible tablet |
| dopaminhydroklorid 160 mg/ml, infusionskoncentrat, ampull 5 ml |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| dopaminhydroklorid 40 mg/ml, infusionskoncentrat, ampull 5 ml |
Dopamine hydrochloride 40 mg/mL solution for injection |
| dopexaminhydroklorid 10 mg/ml, infusionskoncentrat, ampull 5 ml |
Product containing precisely dopexamine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Dornase alfa 2500 E (2,5 mg), lösning för nebulisator |
Dornase alfa 1 mg/mL solution for nebuliser |
| dorsal fingerlambå |
Flap (substance) |
| dorsal metatarsal fasciokutan lambå |
Dorsal metatarsal artery fasciocutaneous flap |
| dorsal tumlambå |
Flap (substance) |
| dorsal tunglambå |
Flap (substance) |
| arteria dorsalis pedis-lambå |
Dorsalis pedis artery flap |
| Dorsolateral sulcus |
Medulla oblongata dorsal lateral sulcus |
| läkemedelsform, indelning efter den lokalisation som den har beretts för |
Pharmaceutical dose form (dose form) |
| språkurval dosenhet singular, nationella läkemedelslistan |
Context-specific terms language type reference set, Swedish national medication list (foundation metadata concept) |
| dotiepinhydroklorid 25 mg/5 ml, oralt elixir |
Dosulepin 5 mg/mL oral solution |
| dotiepinhydroklorid 25 mg/5 ml, sockerfritt elixir |
Dosulepin 5 mg/mL oral solution |
FHIR